Clinical trial Recruiting at 25 sites Interventional Ages 18 and up

Controlling fever in patients with septic shock using external cooling

Official title: Intérêt du Traitement de la fièvre Par Refroidissement Externe Pour la Survie Des Patients ventilés en Choc Septique

Run by Centre Hospitalier Intercommunal Creteil · NCT04494074 · Data updated 2026-11-12

This study tests whether using external cooling to control fever helps people on ventilators with septic shock live longer and feel better compared to letting their fever continue.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment820 (estimated)
SponsorCentre Hospitalier Intercommunal Creteil
Academic / other
Locations33 sites (Amiens and 32 other locations)
StatusRecruiting
StartedOctober 1, 2022
Main results expectedDecember 1, 2028
Study endsDecember 1, 2028
Registry record updatedSeptember 21, 2026
Trial IDNCT04494074 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults with documented or suspected infections leading to septic shock, requiring mechanical ventilation and exhibiting fever.

Probably not a fit

Patients with recent cardiac arrest, acute brain injury, or those under 18 years old will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to compare two strategies for managing fever in mechanically ventilated patients suffering from septic shock. Participants will be randomly assigned to either continue with their fever or to receive external cooling to maintain normothermia. The study seeks to determine which approach leads to better outcomes, particularly focusing on mortality rates at 60 days. The trial builds on previous findings that suggest fever control may improve organ function and reduce mortality in severely ill patients.

Why it matters

Potential benefit: If successful, this study could improve survival rates and organ function in patients with septic shock.

How similar studies have gone: Previous studies have shown promising results with fever control in similar patient populations, indicating potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Documented or suspected infection either communautary or hospital acquired
* Septic shock defined by the need for vasopressor and lactate\>2 mmol/l despite adequate fluid resuscitation (sepsis-3 definition)
* Patients under invasive mechanical ventilation
* Body core temperature\>38.3°C
* Intravenous sedation or opioids
* Ongoing antimicrobial treatment and/or intervention for infection source control
* Attending physician confirms clinical equipoise without substantial risk if the patient participates in the trial
* Informed consent of next of kin/other designated person before inclusion or procedure for inclusion in emergency situation

Exclusion Criteria:

* Cardiac arrest within previous 7 days
* Acute brain injury within previous 7 days
* Extensive burns or epidermal necrolysis
* \<18 years old
* Body core temperature \>41°C
* Under legal guardianship
* No affiliation with the French health-care system
* Pregnancy
* Participation in another interventional study with mortality as the primary endpoint
* An investigator's decision not to resuscitate
* Patient already recruited in the trial

Where it's running

  • CHU Amiens
    Amiens, France
    Recruiting
  • CHU Angers
    Angers, France
    Recruiting
  • CH Victor Dupouy
    Argenteuil, France
    Recruiting
  • Hôpital Nord Franche Comté
    Belfort, France
    Recruiting
  • CH Cholet
    Cholet, France
    Recruiting
  • Centre hospitalier intercommunal de Créteil
    Créteil, France
    Recruiting
Show 27 more locations
  • CHD Dijon
    Dijon, France
    Recruiting
  • CHU Grenoble
    Grenoble, France
    Recruiting
  • GH Est Francilien
    Jossigny, France
    Recruiting
  • CHD Vendée
    La Roche-sur-Yon, France
    Recruiting
  • CHU Le Mans
    Le Mans, France
    Recruiting
  • CH Libourne
    Libourne, France
    Recruiting
  • Hôpital de la Croix-Rousse
    Lyon, France
    Recruiting
  • GRH Mulhouse
    Mulhouse, France
    Recruiting
  • CHU Hotel Dieu
    Nantes, France
    Recruiting
  • Hôpital Pasteur
    Nice, France
    Recruiting
  • Hopital Lariboisière - Réanimation Médicale
    Paris, France
    Recruiting
  • Hôpital Lariboisière -Réanimation chirurgicale
    Paris, France
    Recruiting
  • CHU La Milétrie Poitiers
    Poitiers, France
    Recruiting
  • CHU Charles Nicolle
    Rouen, France
    Recruiting
  • CHU Réunion Sud
    Saint-Denis, France
    Recruiting
  • Hôpital FOCH
    Suresnes, France
    Recruiting
  • CH BIGORRE SITE GESPE Tarbes
    Tarbes, France
    Recruiting
  • CHBA Vannes-Auray
    Vannes, France
    Recruiting
  • Centre Hospitalier Mignot
    Versailles, France
    Recruiting
  • Hôpital Henri Mondor
    Créteil, France
    Active not recruiting
  • CHU Kremlin Bicetre
    Le Kremlin-Bicêtre, France
    Active not recruiting
  • CH Lens
    Lens, France
    Not yet recruiting
  • Hôpital Saint Joseph Saint Luc
    Lyon, France
    Not yet recruiting
  • Hôpital Timone
    Marseille, France
    Active not recruiting
  • CHR Metz Hôpital de Mercy
    Metz, France
    Not yet recruiting
  • CHU Archet 1
    Nice, France
    Active not recruiting
  • CHU Reims
    Reims, France
    Active not recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.